InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others… Jun 14, 2022
InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 9, 2022
InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV May 5, 2022
MariMed Closes Acquisition of Illinois Craft Cannabis License Allowing for Vertically Integrated Operations May 5, 2022
